CVS/Aetna 1Q Results Receive Wall Street Stamp of Approval

CVS Health Corp. impressed Wall Street analysts with strong first-quarter 2021 financial results, which were largely driven by the performance of its PBM and health benefits segments. Evercore ISI analysts, for example, gushed that the diversified health care giant’s results were “exciting” because they provided “some glimmers of the bull thesis playing out.”

“All three segments rowed in unison and put up better than expected results” despite facing challenges in the retail segment, a weak cough/cold/flu season, and a “re-ramping of health care utilization,” the equities analysts wrote in a May 4 note to investors.

0 Comments
© 2023 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

humana-website
February 3

Humana Anticipates Strong EPS Growth in 2023, Cites Individual MA Enrollment Increase

READ MORE
ambulance
February 3

Study Could Help Policymakers Set Fair Reimbursement Rate for Ground Ambulances

READ MORE
call-center
February 3

UnitedHealth, Blues Spinoff Lucet Proffer Behavioral Health Care Access Solutions

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today